share_log

BRIEF-North China Pharmaceutical Says Unit's Anti-Monopoly Case Recinded

BRIEF-North China Pharmaceutical Says Unit's Anti-Monopoly Case Recinded

簡報-華北製藥稱單位反壟斷案重新審理
reuters ·  2021/11/08 04:46

Nov 8 (Reuters) - North China Pharmaceutical Co LTd

路透11月8日電-華北製藥有限公司

600812.SS :

600812.SS:

* SAYS UNIT'S ANTI-MONOPOLY CASE HAS BEEN RECINDED BY U.S. COURT IN NEW YORK

*表示單位的反壟斷案件已被紐約美國法院重新審理

Source text Further company coverage: 600812.SS

源文本進一步公司報道:600812.SS

(Reporting by Hong Kong newsroom)

(香港新聞編輯部報道)

((meg.shen@thomsonreuters.com; 852-39525805;))

(meg.shen@thomsonreurs.com;852-39525805;)

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論